• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Executive Spotlight: Robin Arnott, Founder & CEO of Entheo Digital

Microdose by Microdose
August 4, 2021
in Industry
Reading Time: 2 mins read
A A
Executive Spotlight: Robin Arnott, Founder & CEO of Entheo Digital

This article was originally published on Green Market Report on August 4, 2021

Robin Arnott is the CEO of Entheo Digital, a digital therapeutics company developing and distributing experiences to support psychedelic therapists at all stages of journey work. Robin has been recognized as an early maverick of Virtual Reality since the re-emergence of the field in the early 2010s. His VR experience “SoundSelf: A Technodelic” has been measured to produce states of consciousness comparable to psilocybin, and is currently being ported to mobile VR solutions.

GMR Executive Spotlight Interview Q&A:

Full Name: Robin Arnott

[bsa_pro_ad_space id=2]
ADVERTISEMENT

Title: Founder and Lead Link

Continue on your trip...

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

Company: Entheo Digital

Years at current company: Since Company Founding in Q1 of 2021

Most successful professional accomplishment before psychedelics:

Robin was the lead developer and designer of the VR experience “SoundSelf: A Technodelic.” Measured to produce psychedelic states of consciousness, SoundSelf was originally distributed as entertainment on VR platforms under the Andromeda Entertainment label. Robin’s new company, Entheo Digital, is continuing to develop SoundSelf as a protocol for psychedelic therapy.

Before developing SoundSelf, Robin was a multi-award-winning sound designer for independent video games. He led the audio design for Antichamber, The Stanley Parable, Capsule, and Duskers

Company Mission: Entheo Digital is growing the accessibility and scalability of psychedelic therapy with immersive virtual experiences.

Company’s most successful achievement: Entheo’s first experience SoundSelf has been measured to reliably stimulate psychedelic states of consciousness. They are integrating it into psychedelic therapy protocols as a preparation tool, to ease first-time-journeyers into deep medicine work.

Has the company raised any capital (yes or no): Yes

[bsa_pro_ad_space id=2]
ADVERTISEMENT

if so, how much?: As of this writing (July 28, 2021) Entheo is in the middle of its $1.5M Series Seed. It has raised $700k thus far.

Any plans on raising capital in the future? Yes.

Most important company 5-year goal: Integrate SoundSelf and other immersive experiences as FDA Cleared protocols to assist in all aspects of psychedelic therapy, for assisting therapists and their clients with deep psychological healing.

Purchase Lasix Discount
Tags: Entheo Digital
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Psychedelic Titans with Ben Sessa of Awakn Life Sciences

Psychedelic Titans with Ben Sessa of Awakn Life Sciences

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.